Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
D001702:Biopharmaceutics; D004077:Digoxin / Q000009:adverse effects / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007408:Intestinal Absorption; D009325:Nausea / Q000139:chemically induced; D011208:Powders; D012995:Solubility; D013607:Tablets; D014839:Vomiting / Q000139:chemically induced
D011208:Powders; D013607:Tablets; D004077:Digoxin